| Old Articles: <Older 42611-42620 Newer> |
|---|
 |
The Motley Fool
July 29, 2010
Alyce Lomax |
Target Takes Aim at NYC The big-box retailer takes on the Manhattan market.   |
The Motley Fool
July 29, 2010
Brian Orelli |
Buy, Sell, or Hold: Biotech Generics Generic biotech drugs are coming. Hop on. |
The Motley Fool
July 29, 2010
Morgan Housel |
Buy, Sell, or Hold Ambac Financial? Sell. Now. |
The Motley Fool
July 29, 2010
Rich Smith |
Hey! Who's Flying This Thing? Just how good can UAVs get? |
The Motley Fool
July 29, 2010
Travis Hoium |
Gaming Companies Steer Clear of Las Vegas Las Vegas Sands' move to Asia is nearly finished. |
The Motley Fool
July 29, 2010
Matt Koppenheffer |
Buy, Sell, or Hold E*TRADE Financial? What should investors be doing with E*TRADE's stock right now? |
The Motley Fool
July 29, 2010
Mike Pienciak |
Has Tesoro Already Topped Out? Second-quarter results could be as good as it gets for 2010 and beyond. |
The Motley Fool
July 29, 2010 |
Why We're Buying Noble Analyst David Williamson argues that the offshore drilling industry is attractive in spite of the uncertainties that currently exist. |
The Motley Fool
July 29, 2010
Brian Orelli |
Forget Respect -- Dendreon Needs Sales! Dendreon's Provenge was approved months ago, but the data from the clinical trial supporting the FDA's decision was finally published in the New England Journal of Medicine this week. |
The Motley Fool
July 29, 2010
Alex Dumortier |
Don't Buy The Best Performing Asset of 2010 Zero-coupon Treasury securities may look appealing during periods of market volatility, but quality stocks are the better option |
| <Older 42611-42620 Newer> Return to current articles. |
